ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Metrics to compare | BSFA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBSFAPeersSector | |
---|---|---|---|---|
P/E Ratio | −126.9x | −5.2x | −0.7x | |
PEG Ratio | 0.66 | 0.16 | 0.00 | |
Price/Book | 2.7x | 1.0x | 2.6x | |
Price / LTM Sales | 2.0x | 1.6x | 3.2x | |
Upside (Analyst Target) | - | 39.3% | 47.0% | |
Fair Value Upside | Unlock | 22.5% | 7.5% | Unlock |